US 9630932
Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
granted A61KA61K31/4192A61K31/454
Quick answer
US patent 9630932 (Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors) held by Aurigene Discovery Technologies Limited expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/4192, A61K31/454, A61K31/496, A61K31/5377